CDA and neoplasm: We found that X55 inhibited the growth of 40% of CDA-deficient tumor cell lines (8 of 20) and 22% of CDA-proficient tumor cell lines (2 of 9), without affecting the growth of non-tumor cell lines, regardless of CDA expression status (Fig. 1d and e and Table 1).